Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuropharmacology

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2015.03.012PMID 25823912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

  2014cited by this paper
• Can antipsychotic treatment contribute to drug addiction in schizophrenia?

  2014cited by this paper
• Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.

  2014cited by this paper
• Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.

  2013influential reference
• fMRI of Cocaine Self-Administration in Macaques Reveals Functional Inhibition of Basal Ganglia

  2011influential reference
• The Antipsychotics Olanzapine, Risperidone, Clozapine, and Haloperidol Are D2-Selective Ex Vivo but Not In Vitro

  2010influential reference
• D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats

  2009cited by this paper
• The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

  2009cited by this paper
• Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine

  2008cited by this paper
• Opposing roles for the nucleus accumbens core and shell in cue-induced reinstatement of food-seeking behavior.

  2008cited by this paper
• Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution.

  2008cited by this paper
• Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery

  2008influential reference
• “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time

  2007influential reference
• The Influence of Antipsychotic Treatment on Brain Reward System Reactivity in Schizophrenia Patients

  2007cited by this paper
• Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms.

  2006cited by this paper
• Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics

  2006cited by this paper
• Antischizophrenic Drugs : Chronic Treatment Elevates Dopamine Receptor Binding in Brain

  2006cited by this paper
• Dopamine and conditioned reinforcement

  2005influential reference
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens

  2005cited by this paper
• Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens

  2004influential reference
• 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine

  2004influential reference
• D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

  2004cited by this paper
• Sensitization of Psychomotor Stimulation and Conditioned Reward in Mice: Differential Modulation by Contextual Learning

  2004influential reference
• Extrapyramidal side effects.

  2004cited by this paper
• Potentiated Reinstatement of Cocaine-Seeking Behavior Following D-amphetamine Infusion into the Basolateral Amygdala

  2003cited by this paper
• Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

  2003cited by this paper
• Significant dissociation of brain and plasma kinetics with antipsychotics

  2002cited by this paper
• Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats.

  2001cited by this paper
• Dopamine D2 Receptor Occupancy Is a Common Mechanism Underlying Animal Models of Antipsychotics and Their Clinical Effects

  2001influential reference
• Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.

  2001cited by this paper
• Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

  2001cited by this paper
• Dopamine D2 Receptor Blockade by Haloperidol: 3H-Raclopride Reveals Much Higher Occupancy than EEDQ

  2000cited by this paper
• Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.

  2000cited by this paper
• Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

  2000cited by this paper
• Behavioral Effects of Psychomotor Stimulant Infusions into Amygdaloid Nuclei

  1999cited by this paper
• Controlled, Double-blind Investigation of the Clozapine Discontinuation Symptoms With Conversion to Either Olanzapine or Placebo

  1999cited by this paper
• Adherence to antipsychotic medications.

  1999cited by this paper
• Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.

  1999cited by this paper
• Repeated d-amphetamine enhances stimulated mesoamygdaloid dopamine transmission

  1997cited by this paper
• Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors

  1997cited by this paper
• Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.

  1995cited by this paper
• Effects ofd-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbensd-amphetamine

  1995cited by this paper
• Psychopharmacology: The Fourth Generation of Progress

  1995cited by this paper
• Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

  1995cited by this paper
• Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats.

  1994cited by this paper
• Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations

  1994cited by this paper
• Tardive dyskinesia.

  1993cited by this paper
• Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

  1992cited by this paper
• Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.

  1991cited by this paper
• Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior.

  1989cited by this paper
• The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.

  1989cited by this paper
• Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

  1988cited by this paper
• Modulation of dopaminergic activity in the nucleus accumbens following facilitation or blockade of the dopaminergic transmission in the amygdala: a study by in vivo differential pulse voltammetry.

  1985cited by this paper
• Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

  1983cited by this paper
• Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Functional studies of the central catecholamines.

  1982cited by this paper
• Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity.

  1981cited by this paper
• The acquisition of responding with conditioned reinforcement: Effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine

  1978influential reference
• Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.

  1977cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats

  1976cited by this paper
• Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats.

  1976cited by this paper
• Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.

  1976influential reference
• Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

  1973cited by this paper
• Neuropharmacology

  1958cited by this paper

• Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed

  2025cites this paper
• Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation

  2025cites this paper
• Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications

  2024cites this paper
• Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats.

  2021cites this paper
• Optogenetic Activation of the Basolateral Amygdala Promotes Both Appetitive Conditioning and the Instrumental Pursuit of Reward Cues

  2020cites this paper
• Schizophrenia and drug addiction comorbidity: recent advances in our understanding of behavioural susceptibility and neural mechanisms

  2020cites this paper
• Where and how does d-amphetamine act to reveal antipsychotic-induced dopamine supersensitivity in rats?

  2020influential citation
• University of Groningen Dopamine D-2 up-regulation in psychosis patients after antipsychotic drug treatment

  2020cites this paper
• Dopamine D2 up-regulation in psychosis patients after antipsychotic drug treatment.

  2020cites this paper
• Antipsychotic-evoked dopamine supersensitivity.

  2020cites this paper
• Investigation into effects of chronic treatment with antipsychotics using a combination of behavioural and electrophysiological techniques

  2019cites this paper
• Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort

  2019cites this paper
• Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain

  2019cites this paper
• The basolateral nucleus of the amygdala regulates both the predictive and incentive motivational properties of reward cues

  2019cites this paper
• Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability

  2018cites this paper
• Chronic Administration of Haloperidol and Working Memory : Roles of Caudate Putamen Dopamine Receptors

  2017cites this paper
• Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.

  2017cites this paper
• Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment

  2017cites this paper
• Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

  2017cites this paper
• Le rôle de la neurotensine dans l’expression de la sensibilisation dopaminergique induite par un traitement continu aux antipsychotiques

  2016cites this paper
• High estrogen and chronic haloperidol lead to greater amphetamine-induced BOLD activation in awake, amphetamine-sensitized female rats.

  2016cites this paper
• 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.

  2015influential citation